What BioXcel Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 4 |
| Total trades | 0 | 33 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 150,450 |
| Disposed | 0 | 39,669 |
| Net activity | +0 | +110,781 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Yocca Frank | Chief Scientific Officer | Jun 15 | Exercise / conversion · M | +35 | — | — | 26,210 |
| Steinhart Richard I | Chief Financial Officer | Jun 15 | Exercise / conversion · M | +35 | — | — | 26,335 |
| Mehta Vimal | CEO and President | Jun 15 | Exercise / conversion · M | +219 | — | — | 69,817 |
| Rodriguez Javier | See Remarks | Jun 15 | Exercise / conversion · M | +35 | — | — | 26,838 |
| Yocca Frank | Chief Scientific Officer | May 20 | Open-market sale · S | −6,845 | $1.09 | −$7.43K | 26,175 |
| Mehta Vimal | CEO and President | May 20 | Open-market sale · S | −19,419 | $1.09 | −$21.1K | 69,598 |
| Rodriguez Javier | See Remarks | May 20 | Open-market sale · S | −6,560 | $1.08 | −$7.11K | 26,803 |
| Steinhart Richard I | Chief Financial Officer | May 20 | Open-market sale · S | −6,845 | $1.09 | −$7.43K | 26,300 |
| Yocca Frank | Chief Scientific Officer | May 04 | Exercise / conversion · M | +17,500 | — | — | 33,020 |
| Mehta Vimal | CEO and President | May 04 | Exercise / conversion · M | +49,758 | — | — | 89,017 |
| Rodriguez Javier | See Remarks | May 04 | Exercise / conversion · M | +17,500 | — | — | 33,363 |
| Steinhart Richard I | Chief Financial Officer | May 04 | Exercise / conversion · M | +17,500 | — | — | 33,145 |
| Yocca Frank | Chief Scientific Officer | May 01 | Exercise / conversion · M | +9,000 | — | — | 15,520 |
| Rodriguez Javier | See Remarks | May 01 | Exercise / conversion · M | +9,000 | — | — | 15,863 |
| Steinhart Richard I | Chief Financial Officer | May 01 | Exercise / conversion · M | +9,000 | — | — | 15,645 |
| Mehta Vimal | CEO and President | May 01 | Exercise / conversion · M | +18,000 | — | — | 39,259 |
| Rodriguez Javier | See Remarks | Mar 15 | Exercise / conversion · M | +35 | — | — | 6,863 |
| Yocca Frank | Chief Scientific Officer | Mar 15 | Exercise / conversion · M | +35 | — | — | 6,520 |
| Steinhart Richard I | Chief Financial Officer | Mar 15 | Exercise / conversion · M | +35 | — | — | 6,645 |
| Mehta Vimal | CEO and President | Mar 15 | Exercise / conversion · M | +219 | — | — | 21,259 |
Loading...
